The Precision Peptide Company Inc. (CSE:BPC)
Canada · Delayed Price · Currency is CAD 0.3500
+0.0050 (1.45%)
Oct 9, 2026, 3:50 PM EST
CSE:BPC Balance Sheet
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Cash & Equivalents | 1.75 | 0.96 | 0.14 | 0.05 | 0.08 | 0.81 |
Cash & Short-Term Investments | 1.75 | 0.96 | 0.14 | 0.05 | 0.08 | 0.81 |
Cash Growth | -3.72% | 585.26% | 171.27% | -32.00% | -90.59% | - |
Accounts Receivable | - | 0.01 | 0 | 0.04 | 0.09 | 0.07 |
Other Receivables | 0.1 | 0.07 | 0.02 | 0.01 | 0.04 | 0.02 |
Receivables | 0.1 | 0.07 | 0.02 | 0.05 | 0.13 | 0.08 |
Inventory | 0.36 | 0.07 | - | 0.06 | 0.09 | 0.01 |
Prepaid Expenses | 0.87 | 0.23 | 0.02 | 0.02 | 0.18 | 0.38 |
Total Current Assets | 3.09 | 1.33 | 0.18 | 0.18 | 0.47 | 1.28 |
Property, Plant & Equipment | - | - | - | 0.02 | 0.02 | 0.02 |
Other Intangible Assets | - | - | - | - | 0.01 | 0.04 |
Total Assets | 3.09 | 1.33 | 0.18 | 0.19 | 0.5 | 1.34 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Accounts Payable | 0.4 | 0.35 | 0.49 | 0.24 | 0.13 | 0.03 |
Accrued Expenses | 0.03 | 0.05 | 0.22 | 0.09 | 0.16 | 0.09 |
Short-Term Debt | - | - | 0.02 | - | - | - |
Total Current Liabilities | 0.43 | 0.4 | 0.73 | 0.33 | 0.28 | 0.12 |
Total Liabilities | 0.43 | 0.4 | 0.73 | 0.33 | 0.28 | 0.12 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Common Stock | 12.39 | 8.29 | 2.46 | 1.8 | 0.8 | 0.75 |
Retained Earnings | -12.17 | -8.52 | -3.99 | -2.96 | -1.3 | -0.17 |
Comprehensive Income & Other | 2.43 | 1.15 | 0.98 | 1.02 | 0.72 | 0.65 |
Shareholders' Equity | 2.66 | 0.93 | -0.55 | -0.14 | 0.22 | 1.23 |
Total Liabilities & Equity | 3.09 | 1.33 | 0.18 | 0.19 | 0.5 | 1.34 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Total Debt | - | - | 0.02 | - | - | - |
Net Cash (Debt) | 1.75 | 0.96 | 0.12 | 0.05 | 0.08 | 0.81 |
Net Cash Growth | -3.72% | 685.18% | 136.75% | -32.00% | -90.59% | - |
Net Cash Per Share | 0.04 | 0.04 | 0.02 | 0.01 | 0.02 | 1.22 |
Filing Date Shares Outstanding | 55.64 | 40.52 | 7.71 | 6.58 | 6 | 4.56 |
Total Common Shares Outstanding | 52.63 | 40.44 | 7.71 | 6.16 | 4.61 | 4.53 |
Working Capital | 2.66 | 0.93 | -0.55 | -0.15 | 0.19 | 1.17 |
Book Value Per Share | 0.05 | 0.02 | -0.07 | -0.02 | 0.05 | 0.27 |
Tangible Book Value | 2.66 | 0.93 | -0.55 | -0.14 | 0.21 | 1.19 |
Tangible Book Value Per Share | 0.05 | 0.02 | -0.07 | -0.02 | 0.05 | 0.26 |
Machinery | - | - | - | 0.02 | 0.02 | 0.02 |